Cecilia M Bastos is a prominent inventor based in Westborough, MA (US). She has made significant contributions to the field of immunology through her innovative research and development of ruthenium complexes as immunosuppressive agents. With a total of 2 patents to her name, her work is paving the way for advancements in organ transplantation and autoimmune disease treatment.

Latest Patents

Cecilia's latest patents include a method for inhibiting immune response, which describes the use of ruthenium complexes as immunosuppressive agents. This method aims to prevent or significantly reduce graft rejection in organ and bone marrow transplantation. Additionally, these ruthenium complexes can serve as immunosuppressant drugs for T-lymphocyte mediated autoimmune diseases, such as diabetes, and may also be beneficial in alleviating psoriasis and contact dermatitis. Another patent focuses on novel ruthenium complexes for similar applications, emphasizing their therapeutic potential in treating hyperproliferative vascular disease.

Career Highlights

Cecilia M Bastos is currently associated with Procept Corporation, where she continues her groundbreaking work in immunology. Her research has garnered attention for its potential to improve patient outcomes in transplantation and autoimmune conditions.

Collaborations

Cecilia collaborates with notable colleagues, including Timothy D Ocain and Benito Munoz, who contribute to her innovative projects and research initiatives.

Conclusion

Cecilia M Bastos is a trailblazer in the field of immunosuppressive agents, with her patents reflecting her commitment to advancing medical science. Her work holds promise for improving the lives of individuals facing organ transplantation and autoimmune diseases.

Profile summary based on public USPTO records.